These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 13217736)

  • 1. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 2. The blood coagulation mechanism with especial reference to the prothrombin-proconvertin contents of plasma during long-term ACTH or cortisone therapy.
    FISCHER F; LUND E
    Acta Med Scand; 1954; 149(3):179-85. PubMed ID: 13180225
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of phenylindanedione on the coagulation factors prothrombin, factor V and factor VII and the question of vitamin K resistance].
    PERLICK E
    Klin Wochenschr; 1953 Mar; 31(11-12):261-3. PubMed ID: 13070456
    [No Abstract]   [Full Text] [Related]  

  • 4. The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.
    TAGER M
    Yale J Biol Med; 1953 Apr; 25(5):374-82. PubMed ID: 13057268
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of phenylindanedione on plasma prothrombin and factor V levels and a comparison with the effect of dicumarol.
    BJERKELUND CJ
    Scand J Clin Lab Invest; 1950; 2(2):83-91. PubMed ID: 15424627
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of the relationship of concentrations of prothrombin, proconvertin, and proaccelerin to three methods for measuring prothrombin time.
    GONYEA LM; HJORT P; OWREN PA
    J Lab Clin Med; 1956 Oct; 48(4):624-33. PubMed ID: 13367602
    [No Abstract]   [Full Text] [Related]  

  • 9. Prothrombin and proconvertin in the newborn and during the first year of life.
    DYGGVE H
    Acta Paediatr (Stockh); 1958 May; 47(3):251-9. PubMed ID: 13532682
    [No Abstract]   [Full Text] [Related]  

  • 10. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
    REILLY EB; GOODMAN JR; WARNER GF
    Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of administration of phenindione on blood levels of prothrombin, autoprothrombin I and autoprothrombin II.
    JOHNSON SA; CALDWELL MJ; PRIEST EM
    J Appl Physiol; 1958 Nov; 13(3):411-6. PubMed ID: 13587424
    [No Abstract]   [Full Text] [Related]  

  • 12. The mode of action of phenylindanedione.
    WALKER W; HUNTER RB
    J Clin Pathol; 1954 Aug; 7(3):249-51. PubMed ID: 13192203
    [No Abstract]   [Full Text] [Related]  

  • 13. Some biochemical and electrophoretic studies on purified prothrombin, factor VII (proconvertin) and factor X (Stuart).
    TISHKOFF GH; PECHET L; ALEXANDER B
    Blood; 1960 May; 15():778-90. PubMed ID: 13838500
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analytical study on Quick test; determination of prothrombin, proconvertin, and proaccelerin].
    SOULIER JP; LARRIEU MJ
    Sang; 1952; 23(7):549-59. PubMed ID: 13004906
    [No Abstract]   [Full Text] [Related]  

  • 15. Micromethod for quantitative determination of plasma prothrombin and proconvertin.
    DYGGVE H; LUND E
    Acta Med Scand; 1954; 150(3):207-14. PubMed ID: 13206681
    [No Abstract]   [Full Text] [Related]  

  • 16. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.
    OWREN PA; AAS K
    Scand J Clin Lab Invest; 1951; 3(3):201-8. PubMed ID: 14900966
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of tromexan and dicumarol on clotting time and prothrombin index].
    KRISTENSON A
    Nord Med; 1951 Jul; 46(29):1102-4. PubMed ID: 14863696
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of bishydroxycoumarin (dicumarol) on clotting time of whole blood.
    MAYER GA; CONNELL WF
    J Am Med Assoc; 1956 Jun; 161(9):806-11. PubMed ID: 13319011
    [No Abstract]   [Full Text] [Related]  

  • 19. DO BARBITURATES INFLUENCE THE PROTHROMBIN-PROCONVERTIN LEVEL DURING ANTICOAGULANT THERAPY?
    SAMUELSSON SM; LILIENBERG G
    Scand J Clin Lab Invest; 1965; 17():73-9. PubMed ID: 14260757
    [No Abstract]   [Full Text] [Related]  

  • 20. THE PROTHROMBIN TIME RESPONSE OF RABBITS TO DICUMAROL.
    MILLAR GJ; JAQUES LB; HENRIET M
    Arch Int Pharmacodyn Ther; 1964 Jul; 150():197-219. PubMed ID: 14204495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.